top of page

Revolution Medicine
in the news...

5/23/2024

Dr. Osborne-Wu shares with Parade realistic expectations of what to expect on a typical Mounjaro journey.

Excerpt:

Like most things, Mounjaro and Zepbound will start low and slow for most patients, according to Dr. Osborne-Wu.

"Mounjaro is always started at a dose of 2.5 mg, unless a patient is being switched from another GLP1 agonist such as Ozempic (in which case their provider will describe the dose conversion as appropriate)," she explains. "This is the lowest dose and patient experiences vary in terms of weight loss results. It is often not the most effective dose so most patients will require dose escalation over time."

parade_logo.jpg

4/20/2024

Dr. Glickman talks to Healthline about reasons patients may not lose weight on medical weight loss drugs.

Excerpt:

“To see the best response to a GLP-1 medication, patients should generally follow the six pillars of Lifestyle Medicine,” Glickman says. Those pillars are:

  • Eating a plant-forward diet

  • Regular exercise

  • Managing stress

  • Avoiding substance use

  • Maintaining strong social relationships with family and friends

Healthline Logo Txp (1)_edited.jpg

4/1/2024

Dr. Glickman speaks to Biospace about how an oral version of the weight loss drug GLP-1 could help improve accessibility for patients.

Excerpt:

“The majority of Americans still don’t have access to GLP-1s,” Glickman told BioSpace. He hopes the approval of oral drugs will alleviate some of the pricing burden, as more medications on the market will drive competition... Glickman also pointed out that a small percentage of the population is needle averse enough to not want to inject themselves.

biospace_logo..jpg

3/21/2024

Dr. Glickman speaks to Healthline about why advice to “just diet and exercise” can fall short for people with obesity.

 

Excerpt: “There is still so much misinformation in our society that many patients and even healthcare providers still believe that obesity can be permanently reversed with enough willpower and counting your calories in versus out,” says Michael Glickman, MD, the founder and CEO at Revolution Medicine.

Healthline Logo Txp (1)_edited_edited.jpg

2/24/2024

Dr. Glickman speaks to Woman's World magazine about unexpected weight loss side effects.

Excerpt: "Ozempic face and Ozempic butt have made headlines this year to describe weight loss in more undesirable areas of the body,” he says. “This occurs when the skin has been stretched due to excess fat and doesn’t always shrink back completely.” He adds that hollowing out of the skin typically happens anytime there’s significant, rapid weight loss, and it’s not due to anything specific about Ozempic or similar drugs like Wegovy or Mounjaro."

womans-world-logo-lg.jpg

2/19/2024

Dr. Glickman speaks to For Women First magazine about Ozempic's success, and its potential side effects.

Excerpt: "A study in The Lancet showed the injectable medicine helped people shed almost 10 pounds in a year. It dials down hunger by regulating glucose levels and slowing digestion, so you feel fuller for longer, explains obesity medicine physician Michael L. Glickman, M.D., founder of Revolution Medicine, Health and Fitness. But could it work too well?"

For Women First Logo

2/7/2024

Dr. Jewel Osborne-Wu, of Revolution Medicine, speaks to Healthline Magazine about a study linking moderate to vigorous physical activity to a lower risk of chronic kidney disease.

Excerpt: "Diabetes causes an increase in inflammation, reduction in effective blood flow through the kidneys, and scarring," Osborne-Wu says. "Exercise is known to promote anti-inflammatory markers, increase blood flow, and carry healing biomarkers to areas of damage. It makes sense that a [person with diabetes] may require more exercise than the average person in order to compensate for the damage that has already been occurring."

Healthline Logo Txp (1)_edited_edited.jpg

1/11/2024

Dr. Glickman speaks to Healthline and shares that various factors play a role in what’s being called the “Ozempic plateau.”

 

Excerpt“In our practice, if a patient has reached a plateau on a certain dose, we would increase their dose by one dosing interval and monitor their progress for at least one to two months before making a further decision,” Glickman says. “If we are noticing that weight loss has resumed and continues steadily, we tend to be conservative and keep them on the dose that is working at that time until we see another plateau.”

Healthline Logo

1/8/2024

Dr. Glickman speaks to BioSpace about how biomarkers can help physicians predict which obesity treatments their patients will best respond to.

 

Excerpt“In clinical practice, it is often a trial-and-error process. If a patient doesn't respond—typically defined as at least 5% body weight loss—we go back to the drawing board and try another brand,” Glickman told BioSpace. Ultimately, he said, if the use of biomarkers can help physicians predict which treatments their patients will best respond to, it will “completely revolutionize how we treat obesity.”

BioSpace Logo

11/9/2023

Dr. Glickman speaks to Healthline about the FDA's approved Zepbound and Mounjaro as a weight loss drug.

 

ExcerptDr. Michael Glickman, a family and obesity medicine specialist who founded Revolution Medicine, Health & Fitness in Washington, D.C., told Healthline that Mounjaro is a “blockbuster drug” and “the most effective weight-loss treatment available on the planet, aside from bariatric surgery.”

“We are in a very exciting time right now in the obesity medicine field,” Glickman said. “The obesity epidemic began in the 1970s and for the first time in 50 years we now have several extremely effective treatment options to offer patients.”

Healthline Logo

11/8/2023

Dr. Glickman speaks to Fast Company about the race to develop anti-obesity drugs that could drive supply up and price down.

ExcerptDr. Michael L. Glickman, founder of Revolution Medicine, expects more alternatives to existing weight management options to hit the market soon. “Virtually all large pharmaceutical companies are racing to develop their own line of anti-obesity therapies, which are in various stages of clinical trials,” he says.

He notes that insurance coverage will likely limit access to some of the newer medications receiving approval, as many patients do not have weight loss drug coverage and can’t access treatment at an affordable price. 

fast-company-logo

10/12/2023

Dr. Glickman talks to Yahoo Life about how much weight you can lose in a month, and how long it takes to lose 10 pounds.

ExcerptWeight loss is not a one-size-fits-all approach, Dr. Glickman reminds. “On average, successful weight loss tends to average one to two pounds per week,” he says. “There could be some periods with greater weight loss, and other periods with less, so a net loss of four to eight pounds per month is a healthy target.”

Yahoo Life Logo

10/9/2023

Dr. Glickman speaks to Women's Health about how rapidly you can safely lose weight.

 

Excerpt: For the average person, it isn't realistic to *safely* lose 10 pounds in one month, says Michael Glickman, MD, a board-certified family medicine and obesity medicine physician and founder of Revolution Medicine, Health and Fitness. “Losing weight too rapidly could increase the risk for gallstone formation, and even trigger rebound weight gain, especially if it was achieved by means of severe calorie restriction,” he explains.

Womens-Health-logo

9/30/2023

Dr. Glickman speaks to Parade about how to think about the 7 to 9 AM exercise window and why it works best.

 

Excerpt:  "For many people, their appetite is naturally lowest in the morning which means they can exercise on an empty stomach," [Dr. Glickman] says. "There is mounting evidence that exercising in a fasted state will cause a shift in fuel utilization that favors fat oxidation. This effect may be present for up to 24 hours after the workout—perhaps resulting in additional fat loss when compared to exercise in the fed state."

parade_logo

8/5/2023

Dr. Glickman speaks to The Hill about how alcohol, weed and cigarettes rank when it comes to your health.

 

Excerpt: “Tobacco I would argue is the worse substance of the three, given it has no conceivable benefit even in light amounts, and considerable risks. Tobacco has been linked to increases in heart disease, cancers, and premature mortality, among others,” Glickman expalined. “Alcohol on the other hand, could have benefits at light or moderate amounts, but then risks with large amounts.”

The_Hill_Logo

8/3/2023

Dr. Glickman speaks to BioSpace about how patients curb the desire to drink or smoke after starting GPL-1 treatments.

 

Excerpt: Glickman agreed, saying that patient reports suggest that GLP-1 is “blunting that pleasure response across the board. I think there are so many interplays in the brain that are involved with the dopamine pleasure response, and addiction falls into that.” 

BioSpace Logo

8/2/2023

Dr. Glickman speaks to Livestrong about the differences between the two most popular GLP-1 medications.

 

Excerpt: "There are GLP-1 receptors in the intestines, and Ozempic can target them," says Michael Glickman, MD, a board-certified family medicine and obesity medicine physician. "Doing so creates a downstream effect of reducing general appetite and promoting early satiety."

Livestrong Logo

6/29/2023

Dr. Glickman speaks to Women's Health Magazine about the latest phase 3 trial results for oral semaglutide.

Excerpt: "Many people also report that semaglutide actually quiets the urge to think about eating, giving them more control over their food choices, adds Michael Glickman, MD, a board-certified family medicine and obesity medicine physician and founder of Revolution Medicine, Health and Fitness. As a result, the medication can aid in weight loss, but should be paired with regular exercise and a healthy, balanced diet."

Women's Health Magazine Logo

5/30/2023

Dr. Glickman speaks to BioSpace about the current market for obesity medications.

Excerpt: Glickman said patients often see family, friends or co-workers losing weight and come to learn they may be on a GLP-1 drug, leading them to seek treatment for themselves. More recently, regular media coverage has increased interest. 

“Weight loss can be very contagious,” he said. It’s a very different conversation today than what we were having with people compared to a few years ago.”

BioSpace Logo

3/2/2023

Dr. Glickman speaks to Giddy about symptoms related to obesity, and common myths and misconceptions.

Excerpt: "Our metabolism slows dramatically with attempts at a low-calorie diet, and most studies show significant or full regain of the lost weight within one to two years," Glickman said. "While our metabolism slows, our hunger hormones increase, which makes us feel hungry and tired all the time. The strongest willpower in the world cannot overcome true hunger."

Giddy Logo

2/1/2023

Dr. Glickman speaks to Giddy about how obesity can reduce libido and impact fertility for both men and women.

Excerpt: "For men, obesity can cause lower testosterone levels and reduce the quality of and quantity of your sperm count," Glickman explained. "For women, obesity can cause dysregulation of the hypothalamic-pituitary axis, which regulates our important sex hormones. Imbalances of our sex hormones leads to difficulties with ovulation and lower rates of implantation of an embryo into the uterus."

Giddy Logo

1/18/2023

Dr. Glickman speaks to Giddy about obesogens, and how we can avoid the "forever chemicals" that can impact our weight.

Excerpt: "Obesogens are chemicals that could be linked to metabolic or hormonal dysfunction, which lead to obesity, among other health conditions," according to Michael L. Glickman, M.D., a family and obesity medicine physician in Washington, D.C., and the founder of the specialty practice Revolution Medicine, Health & Fitness. "We can be exposed to obesogens from the foods we eat, the liquids we drink, the products that we touch with our hands or skin, and the air that we breathe. We can even be exposed to obesogens before we are born, through a mother's blood that goes to the placenta."

Giddy Logo

1/18/2023

Dr. Glickman speaks to Giddy about the latest science and understanding of obesity.

Excerpt: "Obesity is caused by our body having an elevated metabolic setpoint, which is the 'weight thermostat' of our body," explained Glickman, who is double-board-certified in family medicine and obesity medicine. "Our brain dictates what our setpoint weight is and works very hard to maintain that weight through hormonal changes and increasing or decreasing the metabolism. Even if we start a low-calorie diet, our brain recognizes these efforts and slows down our metabolism to fight the body to regain weight."

Giddy Logo

12/29/2022

Dr. Glickman featured in CafeMom, speaking about Ozempic and the current medication shortages affecting patients.

Excerpt: "The US has roughly 100 million adults with obesity," Dr. Michael Glickman told the media outlet. "It is no surprise these treatments are experiencing unprecedented demand because we now have treatments that work, even if they are being used largely off-label."

Cafe Mom Logo

12/15/2022

Dr. Glickman speaks to VICE News about the current supply shortages for Ozempic and other weight loss medications that patients are currently facing.

Excerpt: “Patients are calling us and already know exactly which medication they want to try,” [Dr Glickman] says. “In the past most patients didn't know about these medications and doctors would be the ones introducing them to all of the options available."

Vice Logo

12/9/2022

Dr. Glickman speaks to Healthline about the current landscape for weight loss medications, and the future of Mounjaro.

ExcerptDr. Michael Glickman is a family and obesity medicine specialist who founded Revolution Medicine Health and Fitness in Washington, D.C.

He prescribes Mounjaro and Ozempic and called Mounjaro a “blockbuster drug” and “the most effective weight loss treatment available on the planet, aside from bariatric surgery.”

“We are in a very exciting time right now in the obesity medicine field,” Glickman told Healthline in an earlier interview. “The obesity epidemic began in the 1970s and for the first time in 50 years we now have several extremely effective treatment options to offer patients.”

Glickman said he’s seeing the results of the medications every day in people whose obesity is “reversing.”

Healthline Logo
stage_1609638525_edited.jpg

Weight Loss Clinic Locations

Revolution Medicine, Health & Fitness | Weight loss practice in Washington DC Michael Glickman

Washington, DC

1050 Connecticut Ave NW
5th Floor
Washington, DC 20036

Revolution Medicine, Health & Fitness | Weight loss practice in Washington DC Michael Glickman

Arlington, VA

4250 N. Fairfax Dr
Suite 600
Arlington, VA 22203

Revolution Medicine, Health & Fitness | Weight loss practice in Washington DC Michael Glickman

Bethesda, MD

3 Bethesda Metro Center
Suite 700
Bethesda, MD 20814

Revolutions Medicine Health and Fitness is an evidence-based medical weight loss practice that accepts most major insurance plans in-network. Any patient residing in DC, Maryland or Virginia can join the practice. Get started with your 30-day free trial on the day that you register. ​There is no commitment to joining after your first appointment, and the weight loss program can be cancelled at any time. Your satisfaction is our priority! Click here to register.

bottom of page